Evaxion Biotech A/S
(EVAX)
undefined
undefined%
At close: undefined
0.91
-1.63%
Pre-market Jan 06, 2025, 05:44 AM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 | FY18 |
| Net Income | -22.13M | -23.17M | -24.53M | -15.02M | -11.20M | -5.54M |
| Depreciation & Amortization | 615.00K | 571.00K | 344.00K | 105.00K | 81.00K | 74.00K |
| Stock-Based Compensation | 479.00K | 942.00K | 1.38M | 3.41M | 2.36M | 2.07M |
| Other Working Capital | -48.70K | -2.28M | 1.88M | -1.58M | -7.00K | 13.00K |
| Other Non-Cash Items | 2.76M | -243.00K | -171.00K | 919.00K | 1.99M | 1.16M |
| Deferred Income Tax | -984.00K | -998.00K | -190.00K | -2.07M | -825.00K | -735.00K |
| Change in Working Capital | 1.56M | -2.88M | 1.24M | 215.00K | 566.00K | 981.00K |
| Operating Cash Flow | -17.69M | -25.77M | -21.93M | -12.44M | -7.03M | -1.99M |
| Capital Expenditures | -87.00K | -292.00K | -1.36M | -393.00K | -61.00K | -7.00K |
| Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a |
| Purchase of Investments | -6.00K | n/a | n/a | n/a | n/a | n/a |
| Sales Maturities Of Investments | n/a | 24.01K | 29.95K | n/a | n/a | n/a |
| Other Investing Acitivies | 133.00 | -13 | 48.00 | -244.00K | -7.00K | 13.00K |
| Investing Cash Flow | -93.00K | -268.00K | -1.33M | -393.00K | -61.00K | 6.00K |
| Debt Repayment | -632.00K | 7.42M | -289.00K | n/a | 79.00K | 7.93M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.15M | n/a | -3.76M | -202.00K | -13.00K | n/a |
| Financial Cash Flow | 10.69M | 7.85M | 49.80M | 8.82M | 9.51M | 9.03M |
| Net Cash Flow | -7.60M | -18.98M | 26.33M | -3.73M | 2.13M | 6.96M |
| Free Cash Flow | -17.78M | -26.07M | -23.29M | -12.83M | -7.09M | -2.00M |